Conformis nominates Gary Fischetti for election to its Board of Directors

– USA, MA –  Conformis, Inc. (NASDAQ: CFMS) today announced the nomination of Gary Fischetti for his election to the Board of Directors at the 2022 AGM to be held on May 4, 2022, to replace Richard Meelia, who will be retiring from the Board immediately before the AGM.

About Gary P. Fischetti

Mr. Fischetti currently serves as the Chairman of the Board for Orchid Orthopedic Solutions and as a member of the Board at Extremity Medical. He was previously employed for 35 years at Johnson & Johnson (including at its DePuy Synthes orthopedic subsidiaries), where he served in positions of increasing responsibility in multiple businesses, with both domestic and worldwide responsibilities. This included serving as the Company Group Chairman – NA Medical Devices for Johnson & Johnson’s medical device business. He previously also served as the WW Company Group Chairman for the family of DePuy Synthes Companies, which included the Joint Reconstruction, Spine, Trauma, CMF, and Powertools businesses. Before that, he served as the WW Company Group Chairman for all the DePuy Orthopaedic businesses and the Codman franchise, and as the Worldwide President of DePuy Spine.

Mr. Fischetti has a BSBA degree in finance from Villanova University and an M.B.A. from Rutgers University.

About Conformis, Inc.

Conformis is a medical technology company focused on advancing orthopedic patient care and creating a world without joint pain. Its product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant Platinum Services Program as well as data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system. Conformis’ sterile, just-in-time, Surgery-in-a-Box delivery system is available with all of its implants and personalized single-use instruments. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.

For more information: https://www.conformis.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team